Replies to post #12551 on Mast Therapeutics, Inc. (MSTX)

[Rhodey Red]

You are 100% correct that EPIC data Q1'16 is crucial for this company, (and for my investment in it) They must proove that they can bring a trial successfully through PHASE 3 and meet the necessary endpoints.